VAXEQUITY LTD.
Company number 12620906 · Monitor this company
Shareholders' funds
£16,790,623
Balance sheet as at 2023-05-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-05-26
- Dissolved
- 2025-04-21
- Registered office
- Victory House Vision Park, Chivers Way, Histon, Cambridge, CB24 9ZR
- Postcode
- CB24 9ZR
- Capital
- 238 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2023-05-31
- Financial year end
- 31 May
Confirmation statement
- Last statement dated
- 2023-05-25
Nature of business (SIC)
- 72190 Other research and experimental development on natural sciences and engineering
Officers 5 current · 1 resigned
Mike, Dr ROMANOS
Director
Anders HOLMÉN
Director
Tyrell Jermaine RIVERS
Director
Jason Robert, Dr DINGES
Director
William Henry Lewarne, Dr WEST
Director
Group structure
Controlled by ASTRAZENECA UK LIMITED — since 2021-09-21
From persons-with-significant-control filings on the public register.
Contact details
- Website
- vaxequity.co.uk
VaxEquity is a UK biotechnology company developing next generation self-amplifying RNA (saRNA) therapeutics and vaccines.
The class of 2020
42%
of the 587 companies in this sector incorporated in 2020 are still active today; 52% have since been dissolved.
A fact about the year, not a forecast for this company.